Equities

Raia Drogasil S/A

Raia Drogasil S/A

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (BRL)25.29
  • Today's Change0.150 / 0.60%
  • Shares traded4.41m
  • 1 Year change-11.64%
  • Beta0.6134
Data delayed at least 15 minutes, as of Jul 06 2024 00:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The Company operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.

  • Revenue in BRL (TTM)35.14bn
  • Net income in BRL1.05bn
  • Incorporated1935
  • Employees57.71k
  • Location
    Raia Drogasil S/AAv. Corifeu de Azevedo Marques3.097, ButantaSAO PAULO 05.339-900BrazilBRA
  • Phone+55 1 137695678
  • Fax+55 1 137695687
  • Websitehttps://www.rd.com.br
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sendas Distribuidora SA68.63bn698.00m15.48bn80.00k22.273.296.790.22550.51420.514250.633.481.708.90101.37857,862.501.73--2.90--16.31--1.02--0.38691.890.8427--21.98---41.80------
Grupo Mateus SA28.29bn1.22bn16.17bn29.67k13.231.839.170.57170.55310.553112.813.991.874.7010.34--8.179.1010.7611.6122.0022.854.374.871.227.890.3073--22.9931.2216.0032.5449.67--
Atacadao SA110.42bn-643.00m21.38bn95.67k--1.1114.670.1936-0.3051-0.305152.399.151.226.2821.37---0.47942.85-0.95565.8018.9319.34-0.39312.110.67822.800.534346.716.7715.15-145.72--14.43-15.92
Raia Drogasil S/A35.14bn1.05bn43.45bn57.71k41.277.1415.351.240.61280.612820.503.541.813.4013.03609,158.105.575.789.519.2530.0129.923.083.330.51883.190.534344.2516.8818.085.9115.9913.1620.02
Data as of Jul 06 2024. Currency figures normalised to Raia Drogasil S/A's reporting currency: Brazilian Real BRL

Institutional shareholders

19.86%Per cent of shares held by top holders
HolderShares% Held
Schroder Investment Management Ltd.as of 31 May 202456.41m3.28%
RBC Global Asset Management (UK) Ltd.as of 31 May 202449.82m2.90%
Fidelity Management & Research Co. LLCas of 31 May 202447.64m2.77%
The Vanguard Group, Inc.as of 06 Jun 202444.62m2.60%
BlackRock Fund Advisorsas of 06 Jun 202439.92m2.32%
JPMorgan Asset Management (UK) Ltd.as of 30 Jun 202430.59m1.78%
JPMorgan Investment Management, Inc.as of 06 Jun 202421.25m1.24%
Sands Capital Management LLCas of 28 Jun 202417.11m1.00%
APG Asset Management NVas of 31 Dec 202316.91m0.98%
Wasatch Advisors LPas of 31 Mar 202416.89m0.98%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.